Correlation Between Fresh Tracks and Zenas BioPharma,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fresh Tracks and Zenas BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fresh Tracks and Zenas BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fresh Tracks Therapeutics and Zenas BioPharma, Common, you can compare the effects of market volatilities on Fresh Tracks and Zenas BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fresh Tracks with a short position of Zenas BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fresh Tracks and Zenas BioPharma,.

Diversification Opportunities for Fresh Tracks and Zenas BioPharma,

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Fresh and Zenas is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Fresh Tracks Therapeutics and Zenas BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenas BioPharma, Common and Fresh Tracks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fresh Tracks Therapeutics are associated (or correlated) with Zenas BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenas BioPharma, Common has no effect on the direction of Fresh Tracks i.e., Fresh Tracks and Zenas BioPharma, go up and down completely randomly.

Pair Corralation between Fresh Tracks and Zenas BioPharma,

If you would invest  78.00  in Fresh Tracks Therapeutics on September 20, 2024 and sell it today you would earn a total of  0.00  from holding Fresh Tracks Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy4.76%
ValuesDaily Returns

Fresh Tracks Therapeutics  vs.  Zenas BioPharma, Common

 Performance 
       Timeline  
Fresh Tracks Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fresh Tracks Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Fresh Tracks is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Zenas BioPharma, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zenas BioPharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the ETF investors.

Fresh Tracks and Zenas BioPharma, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fresh Tracks and Zenas BioPharma,

The main advantage of trading using opposite Fresh Tracks and Zenas BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fresh Tracks position performs unexpectedly, Zenas BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will offset losses from the drop in Zenas BioPharma,'s long position.
The idea behind Fresh Tracks Therapeutics and Zenas BioPharma, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine